Adaptive behavior critically depends on performance monitoring (PM), the ability to monitor action outcomes and the need to adapt behavior. PM-related brain activity has been linked to guiding decisions about whether action adaptation is warranted. The present study examined whether PM-related brain activity in a flanker task, as measured by electroencephalography (EEG), was associated with adaptive behavior in daily life. Specifically, we were interested in the employment of self-control, operationalized as self-control failures (SCFs), and measured using ecological momentary assessment. Analyses were conducted using an adaptive elastic net regression to predict SCFs from EEG in a sample of 131 participants. The model was fit using within-subject averaged response-locked EEG activity at each electrode and time point within an epoch surrounding the response. We found that higher amplitudes of the error-related negativity (ERN) were related to fewer SCFs. This suggests that lower error-related activity may relate to lower recruitment of interventive self-control in daily life. Altered cognitive control processes, like PM, have been proposed as underlying mechanisms for various mental disorders. Understanding how alterations in PM relate to regulatory control might therefore aid in delineating how these alterations contribute to different psychopathologies.
With the increasing availability of online streaming platforms, their large repertoire of shows, and policy to release entire seasons at once, binge-watching (BW)-subsequently watching multiple episodes (Trouleau et al., 2016;Walton-Pattison et al., 2018)-attracts growing theoretical and empirical interest (Schlütz, 2015). BW is a popular and rewarding leisure activity that should not be unnecessarily pathologized (Billieux et al., 2015). However, BW does entail problematic potential as it is linked to negative outcomes such as sleeping
Disorders marked by high levels of impulsivity and compulsivity have
been linked to changes in performance monitoring, specifically the
error-related negativity (ERN). We investigated the relationship between
performance monitoring and individual differences in impulsivity and
compulsivity. A total of 142 participants were recruited into four
groups, each with different combinations of impulsivity and
compulsivity, and they performed a flanker task to assess error-related
brain activity. We defined error-related brain activity as ERN amplitude
and theta power. Single trial regression was employed to analyze the
amplitude differences between incorrect and correct trials within the
ERN time window. The findings revealed that impulsivity, compulsivity
and different measures of response processing exhibited distinct
interactions, which were influenced by the configuration of impulsivity
and compulsivity, but also depending on the measure of response
processing. Specifically, high compulsivity predicted larger ERN
amplitudes in individuals with low impulsivity, whereas high impulsivity
had no effect on ERN amplitude in individuals with low compulsivity.
Furthermore, when both impulsivity and compulsivity were high, no
increase in ERN amplitude was observed; instead, there was a reduced
difference between incorrect and correct trials. No significant
differences were found for theta power. While the association between
error-related brain activity and transdiagnostic markers or
psychopathology may be smaller than generally assumed, considering the
interaction between different transdiagnostic markers and their facets
can enhance our understanding of the complex associations that arise
during the investigation of neural correlates of performance monitoring,
specifically the ERN.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.